Prevalence of adequate control of increased serum low-density lipoprotein cholesterol in self-pay or Medicare patients versus Medicaid or private insurance patients followed in a University General Medicine Clinic

American Journal of Cardiology

Volumn 95, Issue 2, 2005, Pages 269-270

  Varma, Raja ^a   Aronow, Wilbert S ^a,b   Gandelman, Glenn ^a   Zammit, Christopher ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CONTROL; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; PATIENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNIVERSITY HOSPITAL; VASCULAR DISEASE;

AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; FEMALE; FINANCING, PERSONAL; HOSPITALS, UNIVERSITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INSURANCE, HEALTH; MALE; MEDICAID; MEDICALLY UNINSURED; MEDICARE; NEW YORK; OUTPATIENT CLINICS, HOSPITAL; PRACTICE GUIDELINES; PREVALENCE;

EID: 11844264536     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.08.095     Document Type: Article

References (9)

1. W.S. Aronow Should the National Cholesterol Education Program guidelines be changed for persons at high risk for cardiovascular events? Preventive Cardiol 7 2004 71 72
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
3. D.J. Harnick, J.L. Cohen, C.B. Schechter, V. Fuster, D.A. Smith Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease Am J Cardiol 81 1998 1416 1420
4. L.L. Lai, M. Poblet, C. Bello Are patients with hyperlipidemia being treated? Investigation of cholesterol treatment practices in an HMO primate care setting Southern Med J 93 2000 283 286
5. L.M. Latts Assessing the results: phase 1 hyperlipidemia outcomes in 27 health plans Am J Med 110 suppl 6A 2001 17S 23S
6. P.D.R. Higgins, C. Russo, M. Scheurer, W.L. Duvall How well do we treat elevated LDL cholesterol? Results from a university residents' clinic NC Med J 63 2002 247 252
7. J. Ruof, G. Klein, W. Marz, H. Wollschlager, A. Neiss, M. Wehling Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns Preventive Med 35 2002 48 53
8. T.A. Pearson, I. Laurora, H. Chu, S. Kafonek The Lipid Treatment Assessment Project (L-TAP) A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160 2000 459 467
9. H.G. Schrott, V. Bittner, E. Vittinghoff, D.M. Herrington, S. Hulley HERS Research GroupAdherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study. JAMA 277 1997 1281 1286